UNITED
      STATES


SECURITIES
      AND EXCHANGE COMMISSION


WASHINGTON,
      D.C. 20549





**FORM
      10-KSB**





xANNUAL
      REPORT PURSUANT
      TO SECTION 13 OR 15(d) OF THE SECURITIES


EXCHANGE
      ACT OF 1934





**For
      the Fiscal Year Ended December 31, 2007**





OR




oTRANSITION
      REPORT
      PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES


EXCHANGE
      ACT OF 1934





For
      the
      transition period from **N/A** to **N/A**


Commission
      File Number: **333-137170**





**Bond
      Laboratories, Inc.**


(Name
      of
      small business issuer as specified in its charter)


**Nevada**
              
              **20-3464383**State
                  of Incorporation
              
              IRS
                  Employer Identification No.




**777
      South Highway 101, Suite 215, Solana Beach, CA 92975**


(Address
      of principal executive offices)





Registrant's
      telephone number, including Area Code: **(858)
      847-9000**


Securities
      registered pursuant to Section 12(b) of the Act: None


Securities
      registered pursuant to Section 12(g) of the Act:





**Common
      Stock, $.01 Par Value**





Check
      whether the Registrant (1) has filed all reports required to be filed by Section
      13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months
      (or
      for such shorter period that the Registrant was required to file such reports)
      and (2) has been subject to such filing requirements for the past 90
      days.




YES x NO
o





Check
      if
      disclosure of delinquent filers in response to Item 405 of Regulation S-B is
      not
      contained in this form, and no disclosure will be contained, to the best of
      the
      Registrant's knowledge, in definitive proxy or information statements
      incorporated by reference in Part III of this Form 10-KSB or any amendment
      to
      this Form 10-KSB. x





Registrant’s
      revenues for the most recent fiscal year were $ 11,530





The
      aggregate market value of the common stock held by non-affiliates computed
      based
      on the closing price of such stock on February 20, 2008, was approximately
      $20,181,675





Transitional
      Small Business Disclosure Format (check one): Yes oNo x





Indicate
      by check mark whether the registrant is a shell company (as defined in Rule
      12b-2 of the Exchange Act.


Yes
oNo
x









FORM
      10-KSB - INDEX





**TABLE
      OF CONTENTS**




PAGEPART
                  IItem
                  1.
              Description
                  of Business
              
              3Item
                  2.
              Description
                  of Property
              
              6Item
                  3.
              Legal
                  Proceedings
              
              6Item
                  4.
              Submission
                  of Matters to Vote of Security Holders
              
              6PART
                  IIItem
                  5.
              Market
                  for Common Equity, Related Stockholder Mattersand
                  Small Business Issuer Purchases of Equity Securities
              
              6Item
                  6.
              Management’s
                  Discussion and Analysis or Plan of Operation
              
              8Item
                  7.
              Financial
                  Statements
              
              14Item
                  8.
              Changes
                      in and Disagreements with Accountants on Accountingand
                  Financial Disclosure
              
              15Item
                  8A.
              Controls
                  and Procedures
              
              15Item
                  8B.
              Other
                  Information
              
              16PART
                  IIIItem
                  9.
              Directors,
                  Executive Officers, Promoters and Control Persons;Compliance
                  with Section 16(a) of the Exchange Act
              
              16Item
                  10.
              Executive
                  Compensation
              
              17Item
                  11.
              Security
                  Ownership of Certain Beneficial Owners and Managementand
                  Related Stockholder Matters
              
              20Item
                  12.
              Certain
                  Relationships and Related Transactions
              
              22Item
                  13.
              Exhibits
              
              22Item
                  14
              Principal
                  Accountant Fees and Services
              
              23Signatures
              
              
              24Certifications




2




**PART
      I**





**ITEM
      1. DESCRIPTION OF BUSINESS.**





Except
      for historical information contained herein, the following discussion contains
      forward-looking statements that involve risks and uncertainties. Such
      forward-looking statements include, but are not limited to, statements regarding
      future events and the Company’s plans and expectations. Actual results could
      differ materially from those discussed herein. Factors that could cause or
      contribute to such differences include, but are not limited to, those discussed
      elsewhere in this Form 10-KSB or incorporated herein by reference, including
      those set forth in *Management’s
      Discussion and Analysis or Plan of Operation.*





**Overview**




As
      people
      live longer and healthcare costs continue to rise at substantial multiples
      to
      the cost of living, consumers are recognizing that prevention is far more
      economical than prescription cures. Capitalizing on this trend, Bond
      Laboratories brought together a seasoned team with a solid track record of
      converting ideas into highly profitable, consumption-driven products and being
      on the leading edge of innovation. Bond is now pursuing its unique vision for
      the next generation of preventative health products; Fortified Beverages and
      Foods.




***Health:*** There is
      a growing recognition that physical and mental wellbeing matter. The report
      by
      Datamonitor (DTM.L), London, U.K. discloses statistics that show that an
      overwhelming majority of European and U.S. consumers feel that improving their
      health is important. Even more significant is that 64% of Europeans and U.S.
      consumers actually took "steps" to improve their health during 2003-04.
      Datamonitor also identifies the crossover trend of health and convenience
      (health on-the-go) as an under-targeted opportunity with high growth potential.






***Convenience:*** The
      demand for easier, faster and disposable products. Convenience, time saving
      products, and “quick fixes” are important to 82% of European and U.S. consumers.
      Convenience is also impacting personal care consumption; 57% of European and
      U.S. consumers report that they groom while on-the-move and 58% admit to
      grooming at-work. Bond Laboratories is ideally positioned to leverage the
      opportunity of providing products to this broad consumer base.




Bond
      Laboratories is set up to cater to all five of the major distribution channels;
      focusing on the three most profitable categories of the industry- Energy, Pain
      Relief and Weight loss. Based upon our extensive research, we strongly believe
      that our liquid energy product would make for an extremely successful initial
      product offering to the public markets.




In
      November , 2007 Bond Laboratories introduced the Fusion.6+ hr. 2 oz. energy
      shot
      at the NACS show in Atlanta, Ga. The public’s initial reaction to Fusion has
      been incredible. We have begun to receive orders from some of the largest
      C-store chains, drug store chains, sporting goods stores, , and health clubs
      in
      the nation. In addition, Management has prior relationships with some the
      nation’s biggest distributors. This should provide Fusion incredible exposure to
      every type of consumer that is looking for energy that is: easy to consume,
      won’t leave you feeling bloated, provides instant energy and will not leave you
      with a crash after drinking it.


**Initial
      Target Market: Energy**




**Product:
      Fusion**




The
      significance of being one of the first brands to market cannot be overlooked.
      Energy Drinks began their popularity with products like Red Bull in the late
      1980’s. Although there are over 600 energy drinks on the market today, it is
      estimated that Red Bull sold over 5 Billion units in 2007. The concentrated
      2
      ounce energy shot drink began approximately 3 years ago with about 15 brands
      in
      the category today; the first, ‘5 Hour Energy’ is expected to have had sales of
      well in excess of $100 million for 2007. Bond launched its Fusion Energy Shot
      at
      the National Association of Convenience Stores in November of 2007 where it
      was
      voted Best Taste.




3




**Fusion
      Product Features** **:**




·
            Triple
                the kick of the typical canned energy drink in a small 2oz.
                shot!





·
            Metabolizes
                faster than canned energy drink**




·
            ****Zero
                carbs, Zero grams of sugar, only 8 calories per serving





·
            No
                crash- as associated with all sugar based energy drinks




·
            The
                strongest / longest lasting energy shot available on the
                market





·
            Recently
                voted the #1 tasting energy shot in the category at the 2007 NACS
                Show!





·
            Available
                in Berry flavor now, with Limon flavor launching in March
                2008





**Competition**





Bond
      Laboratories will encounter competition in each market that they enter. Patent
      and Trademark applications that cover new embodiments of technology will be
      pursued wherever possible. While the Company cannot assure that the patents
      and
      applications will block competitive products, they should help the Company
      become a significant participant in the marketplace.


The
        industry leader is Red Bull with annual sales of approximately $5 billion.
        The
        other leaders in the category include Monster, (manufactured and distributed
        by
        Hanson Beverages), RockStar, (now distributed by Coca Cola along with its
        own
        brand ‘Full Throttle’), Amp, (manufactured and distributed by Pepsi) and SoBe,
        (also manufactured and distributed by Pepsi). To managements’ knowledge and
        observation, almost all energy products are sold in 8 - 24 ounce cans. As
        of the
        end of 2007, there were more than 600 brands in the energy can drink business,
        with close to 200 going out of business that year and 200 new entries to
        take
        their place. Fusion is sold in a 2 ounce shot with the same ‘kick’ as a 24 ounce
        energy drink. This gives ‘Fusion’ a major advantage that is stressed to the
        consumers in all marketing materials. Not only is it easier to carry around
        a
        small bottle, vs. several cans, (which must stay cold), but cans use science
        and
        technology from over ten years ago. Where the energy can market is dominated
        by
        major brands with sales exceeding $500 mm - $5 billion, the shot market only
        has
        approximately 15 brands, of which only one, 5 Hour Energy has sales exceeding
        $100 mm. Since 1995, there have been great discoveries in energy producing
        nutrients. More important, studies have clearly demonstrated that most
        ingredients are not stable in normal carbonated beverage products and that
        the
        longer they stay in contact with liquid, the less potent they become.




**Distribution
      Plan**




**Key
      Relationships: WMG**




In
      November of 2007, Bond Laboratories entered into a consulting and marketing
      agreement with Wasserman Media Group to formulate and implement a product
      design/promotion/sponsorship/media plan for the Fusion line of Energy Products.




4




Fusion
      will reach out to America’s youth subcultures through an aggressive media and
      events marketing plan targeted at action sports through a strategic partnership
      with Wasserman Media Group (WMG)




WMG
      Strengths:




·
            SPONSORSHIPS-
                WMG represents some of the most talented athletes across baseball,
                basketball, BMX, motocross, skateboarding, snowboarding, soccer and
                surfing. Several of WMG’s athletes were the first to endorse Monster
                Energy Drinks and largely acknowledged for helping to build it into
                a $850
                million brand.




·
            MARKETING-
                WMG secures naming rights for popular sports and entertainment
                destinations, generates corporate sponsorships, and develops marketing
                programs for leading consumer brands.




·
            CONTENT-
                WMG also develops, markets and distributes leading-edge sports and
                entertainment content via all forms of media including television,
                retail
                and online platforms as well as live events.




Future
      Bond Labs, quality of life products, are currently being finalized.




**Partners
      vs. Representation**





Most
      new
      companies conceive an idea, test market and then seek out a distributor or
      attempt to get retail space directly. This means that the brokers who will
      represent and support the new product through the distribution channels are
      not
      directly involved in the development of the product or emotionally invested
      in
      the lifecycle of the product. By contrast, Bond is partnering in advance with
      well established brokers in each of the five major areas of distribution, not
      only contracting for their services at market rates, but incentivizing them
      with
      equity in the company that they can vest into over the course of the success
      of
      each products life. Too often, the product representative opens the difficult
      door for a new product/company, only to watch them grow substantially, but
      not
      getting the opportunity to participate in the increased overall value of the
      ‘brand’, due to their initial and ongoing efforts. Management believes that as
      initial shareholders in the Company, these distributors will keep its products
      at the top of their priority list and take every effort to make sure that new
      ideas and concepts are being considered by Bond before anyone else.





**Revenues**





Revenue
      from product sales is recognized upon shipment to customers at which time such
      customers are invoiced. Units are shipped under the terms of FOB shipping point
      when determination is made that collectibility is probable. Revenues for
      services are recognized upon completion of the services. For consulting services
      and other fee-for-service arrangements, revenue is recognized upon completion
      of
      the services. The Company has adopted the Securities and Exchange Commission’s
      Staff Accounting Bulletin (SAB) No. 104, which provides guidance on the
      recognition, presentation and disclosure of revenue in financial
      statements. ****





Additional
      Information





Bond
      files reports and other materials with the Securities and Exchange Commission.
      These documents may be inspected and copied at the Securities and Exchange
      Commission, Judiciary
      Plaza, 100 F Street, N.E., Room 1580, Washington, D.C. 20549 .
      You can
      obtain information on the operation of the Public Reference Room by calling
      the
      Commission at 1-800-SEC-0330. You can also get copies of documents that the
      Company files with the Commission through the Commission’s Internet site at www.sec.gov .




5





**ITEM
      2. DESCRIPTION OF PROPERTY.**




The
      Company operates as a company headquartered in Solana Beach, CA. On May 17,
      2006, the Company signed a one year lease to rent space for $1,770 per month.
      On
      July 3, 2006, the Company entered into a lease for 1,875 of office warehouse
      space in Murrieta, CA. The term of the lease is for two years with rent of
      $1,968 per month beginning September 1, 2006. This facility was subsequently
      sublet when the Company changed its distribution model to using a fulfillment
      house who could not only warehouse product, but pull all orders and facilitate
      all shipping.





**ITEM
      3. LEGAL PROCEEDINGS**





We
      are
      not a party to any pending material legal proceedings and are not aware of
      any
      threatened or contemplated proceeding by any governmental authority against
      us.





**ITEM
      4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.**





The
      Company submitted no matters to a vote of its security holders during the fiscal
      year ended December 31, 2007.




**PART
      II**





**ITEM
      5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER
      MATTERS.**





Bond
      common stock is traded in the over-the-counter market, and quoted in the
      National Association of Securities Dealers Inter-dealer Quotation System
      (“Electronic Bulletin Board) and can be accessed on the Internet at www.otcbb.com under
      the symbol “BNLB.OB”





At
      December 31, 2007, there were 20,431,450 shares of common stock of Bond that
      were issued to approximately 127 shareholders of record of the Company’s common
      stock.





The
      following table sets forth for the periods indicated the high and low bid
      quotations for Bond’s common stock. These quotations represent inter-dealer
      quotations, without adjustment for retail markup, markdown or commission and
      may
      not represent actual transactions.





**Periods**
            
            **High**
            
            **Low****Fiscal
                Year 2007**First
                Quarter (January - March 2007)
            
            $
            00
            
            $
            .00Second
                Quarter (April - June 2007)
            
            $
            00
            
            $
            00Third
                Quarter (July - September 2007)
            
            $
            1.75
            
            $
            3.00Fourth
                Quarter (October - December 2007)
            
            $
            3.25
            
            $
            3.00**Fiscal
                Year 2006**First
                Quarter (January - March 2006)
            
            $
            00.
            
            $
            .
                00Second
                Quarter (April - June 2006)
            
            $
            .
                00
            
            $
            .
                00Third
                Quarter (July - September 2006)
            
            $
            00
            
            $
            .00Fourth
                Quarter (October - December 2006)
            
            $
            .00
            
            $
            .00





Bond
      has
      never paid dividends on any of its common stock shares. Bond does not anticipate
      paying dividends at any time in the foreseeable future and any profits will
      be
      reinvested in Bond’s business. Bond’s Transfer Agent and Registrar for the
      common stock is Colonial Stock Transfer located in Salt Lake City,
      Utah.





**Sale
      of Unregistered Securities**


**Stock
                  issued**
              
              **Cash**
              
              **Stock
                  issued**
              
              **Stock
                  issued for**
              
              **Stock
                  issued for****Year
                    Ended**
              
              **for
                  Cash**
              
              **Received**
              
              **for
                  Services**
              
              **Debt
                  Conversion**
              
              **Stock
                  Split**December
                  31, 2007
              
              
              2,014,000
              
              $
              1,651,000
              
              
              2,517,625
              
              
              1,878,600
              
              
              9,067,225December
                  31, 2006
              
              
              -
              
              
              -
              
              
              4,954,000
              
              
              -Total
                  Issued
              
              
              2,014,000
              
              $
              1,651,000
              
              
              7,471,625
              
              
              1,878,600
              
              
              9,067,225





6




During
      the year ended December 31, 2006, the Company has issued shares of its common
      stock as consideration to consultants for the fair value of the services
      rendered. The value of those shares is determined based on the trading value
      of
      the stock at the dates on which the agreements were into for the services and
      the value of services rendered. During the year ended December 31, 2006, the
      Company granted to consultants, 4,954,000 shares of common stock valued in
      the
      aggregate at $49,540 with a strike price of par value since the company was
      not
      trading its common stock. The stock issued for services includes $49,540 of
      the
      compensation for services rendered in accordance with the consultant respective
      agreements. The offer and sale of such shares of our common stock were effected
      in reliance on the exemptions for sales of securities not involving a public
      offering, as set forth in Rule 506 promulgated under the Securities Act and
      in
      Section 4(2) of the Securities Act. A legend was placed on the certificates
      representing each such security stating that it was restricted and could only
      be
      transferred if subsequent registered under the Securities Act or transferred
      in
      a transaction exempt from registration under the Securities Act.





During
      the year ended December 31, 2007, the Company has issued shares of its common
      stock as consideration to consultants for the fair value of the services
      rendered. The value of those shares is determined based on the trading value
      of
      the stock at the dates on which the agreements were into for the services and
      the value of services rendered. During the year ended December 31, 2007, the
      Company granted to consultants, 2,517,625 shares of common stock valued in
      the
      aggregate at $3,109,477 with a strike price of par value since the Company
      was
      not trading its common stock. The stock issued for services includes $3,109,477
      of the compensation for services rendered in accordance with the consultant
      respective agreements. The offer and sale of such shares of our common stock
      were effected in reliance on the exemptions for sales of securities not
      involving a public offering, as set forth in Rule 506 promulgated under the
      Securities Act and in Section 4(2) of the Securities Act. A legend was placed
      on
      the certificates representing each such security stating that it was restricted
      and could only be transferred if subsequent registered under the Securities
      Act
      or transferred in a transaction exempt from registration under the Securities
      Act.





During
      the year ended December 31, 2007, the Company issued 2,014,000 shares of its
      common stock for $1,651,000. The shares were issued to third parties in a
      private placement of the Company’s common stock. The shares were sold throughout
      the year ended December 31, 2007, at $.82 through $1.00 per share at the end
      of
      the year when the shares were sold. The offer and sale of such shares of our
      common stock were effected in reliance on the exemptions for sales of securities
      not involving a public offering, as set forth in Rule 506 promulgated under
      the
      Securities Act and in Section 4(2) of the Securities Act, based on the
      following: (a) the investors confirmed to us that they were “accredited
      investors,” as defined in Rule 501 of Regulation D promulgated under the
      Securities Act and had such background, education and experience in financial
      and business matters as to be able to evaluate the merits and risks of an
      investment in the securities; (b) there was no public offering or general
      solicitation with respect to the offering; (c) the investors were provided
      with
      certain disclosure materials and all other information requested with respect
      to
      our company; (d) the investors acknowledged that all securities being purchased
      were “restricted securities” for purposes of the Securities Act, and agreed to
      transfer such securities only in a transaction registered under the Securities
      Act or exempt from registration under the Securities Act; and (e) a legend
      was
      placed on the certificates representing each such security stating that it
      was
      restricted and could only be transferred if subsequent registered under the
      Securities Act or transferred in a transaction exempt from registration under
      the Securities Act.





During
      year ended December 31, 2007, the Company issued 1,238,600 shares of its common
      stock for the conversion of debt in the amount of $815,000 plus accrued interest
      of $24,313 with the total conversion of $839,313. The Company issued 230,000
      common shares for the conversion of debt from the accrued salary of the
      Company’s CEO of $230,000. Also the Company issued 410,000 common shares for the
      conversion of affiliate debt of $119,606. All of these conversions were non-cash
      transactions as reflected in the statement of Cash Flow. The Company issued
      1,238,600 in warrants in connection with this conversion of debt.




7





**Stock
      Splits**





Share
      data in this report have been adjusted to reflect the following stock splits
      relating to the Company's common stock: December 7, 2007 the board of directors
      authorized a 2-for-1 forward split. The Company declared the 2 for 1 forward
      split was distributed on January 8, 2008. This forward split is reflected in
      the
      statement of shareholder’s equity for December 31, 2007 as an increase in common
      stock of 9,067,225.





**ITEM
      6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF
      OPERATION**





Management’s
      discussion and analysis contains statements that are forward-looking and involve
      risks and uncertainties. Several factors could cause actual results to differ
      materially from those described in such forward-looking statements. This
      includes the Company’s ability to manage growth, involvement in litigation,
      competition in the health produce industry, ongoing contractual relationships,
      dependence upon key personnel, changes in customer demand for product and
      services, and the adoption of new, or changes in, accounting policies, practices
      and estimates and the application of such policies, practices, and estimates,
      and federal and state governmental regulation, specifically in the areas of
      electronic transaction processing in the health care industries.





The
      following financial data should be read in conjunction with the financial
      statements of Bond and related notes and other financial information appearing
      elsewhere in this report.




**Plan
      of Operations**




We
      were
      incorporated in Nevada in July of 2005. The focus of the company has always
      been
      to develop an alternative nutraceutical dietary supplement delivery platform
      vs.
      antiquated capsules and pills. Two trends have lead Management to believe an
      enormous window of opportunity was developing in the supplement business that
      would change consumers’ purchasing habits across the board:




With
      the
      constant increase in healthcare, consumers were going to focus on prevention
      in
      greater numbers, to reduce the costs of eventual treatment, increasing their
      commitment and consumption of dietary supplements.




Consumers
      are living longer, but as they get older, their stomach’s ability to process
      capsules and pills reduces. In fact, delivery of supplements through the stomach
      is one of the least effective ways for the body to get the benefits of the
      ingredients. It is not unusual for 75%+ of the contents to dissipate through
      the
      liver before traveling to the parts of the body it is intended for.




In
      September of 2005, we assembled a core group of individuals with extensive
      backgrounds and experience in the Nutraceutical Supplement business to form
      our
      development team. As we were relying upon limited funds from one of the
      principles and a few individuals who had invested with him in the past, everyone
      was brought on in a consulting capacity enabling us to maximize our cash by
      paying for only time actually used. Several of these people were also granted
      founders shares. This kept our initial overhead below $20,000 per month.




It
      was
      concluded early on, that the Company should limit its focus to the three largest
      SKU’s in the Supplement business; Energy, Pain Relief and Diet. The Company
      would not focus on commodity products like individual Vitamins A, B, C, D,
      E,
      etc... as they remain very low margin products with numerous large competitors
      dominating the space. Of these three categories, it was determined that Energy
      would be the easiest and least expensive product line to introduce first, at
      the
      same time enabling the Company to explore the challenges of delivering
      ingredients through a powder vs. traditional capsules and pills.




8




When
      we
      first began our research, there were over 100 Energy drinks on the market,
      but
      only a handful of powders, of which two dominated the retail market; Zipfizz
      and
      Rip It, (an extension of the Rip It Energy Drink). Zipfizz sold 20 million
      individual serving tubes in 2005. Having determined that the largest groups
      of
      consumers of Energy drinks were between the ages of 18 and 30 with the majority
      of those between 18 and 22, we decided to go target the college markets first.
      From September through December we worked on formulations, branding and
      packaging. The name for the product we selected was Fusion. Three flavors were
      developed, Atomic (a lemon line flavor similar to existing energy drinks on
      the
      market), Sunrise, (a tangerine/orange flavor and Cosmo, (a strawberry
      punch).




In
      January of 2006 we completed our packaging, determined pricing and contracted
      with a laboratory in Arizona to manufacture our first production. We began
      our
      first test marketing in February at San Diego State University and the
      University of California at San Diego. Cards were handed out on campus that
      invited the students to log onto our web site to receive a free sample box
      of
      Fusion. Approximately 4,000 cards were dispersed that resulted in over 400
      responses, a very high percentage based on the fact that the students actually
      had to hold onto the card until they got home and then log onto the web site
      and
      provide their personal contact information.




From
      inception to test marketing we expended approximately $150,000.




With
      close to a 10% response rate on our ‘Give Away’ cards, we projected that
      approximately 10% of those individuals would become customers and place
      replacement orders. We were quite disappointed when less than 1% followed
      through and were forced to go back and revisit our assumptions. We concluded
      that there were three areas that would account for the limited
      results:




·
            Taste/energy
                level achieved




·
            Price




·
            Distribution
                method




In
      April
      we decided to test a new distribution model by selling Fusion at a few local
      street fairs. We handed out 2 ounce samples, sold 16 ounce pre-mixed cups and
      box sets of 5 tubes, cups and a stirrer. These results were far more positive.
      At each fair, we handed out approximately 2,000 samples, sold approximately
      200+
      cups and about 50 boxes. In each box was a card explaining how to re-order
      Fusion from our web site, which several customers continued to do.




We
      revamped our marketing and distribution model. Our target consumer became adults
      between the ages of 25 and 60. It was also determined that needed develop a
      distribution network in advance of bringing the product to market and that
      we
      must take control of our production. To accomplish the first of these steps,
      we
      decided to offer equity to certain groups that had distribution relationships
      in
      the retail outlets that cater to our newly defined target market. They vest
      into
      their ownership based on their success. We have not asked them to discount
      their
      services.




In
      July
      of 2007, we concluded that the taste and effects of our product were meeting
      or
      exceeding the expectations of our identified target market, but our delivery
      platform of a powder did not meet the convenience desire as it required the
      consumer to locate water to blend the mixture. It was at this point that we
      began our focus on the 2 ounce shot. By November we were able to begin testing
      for consumer approval and launched the Fusion 6 Hour Energy Shot at the National
      Convenience Store show. From there, we ordered our first production of 250,000
      bottles with a delivery target to retail shelves of the first week in
      January.




9




We
      have
      been dependent upon funding from certain stockholders to sustain our operations.




Completion
      of these projects as well as our ability to satisfy our operational and overhead
      expense requirements beyond 2007 is dependent on our raising additional capital.
      Should we fail to generate sufficient cash inflows either from operations or
      through future equity or debt sales, we may not be able to implement our
      business plan, complete any of these projects, or sustain our operations through
      the second quarter of 2008.




Further
      product development and fulfillment of the distribution channels we are planning
      to pursue will require us to use the funds received through this offering.
      The
      research and development/product development and full production costs will
      total approximately $1,000,000 to fulfill our strategic goals. To effectively
      launch on a nationwide basis will require an additional $1,000,000.




As
      discussed in our risk factors, our business operates in a highly competitive
      environment. Continued economic slowdown as a result of terrorist attacks,
      market decline, the war in Iraq, or a combination thereof appears to have
      resulted in a general reduction of external capital available to start-up
      nutraceutical companies. In addition, new products or delivery platforms could
      be developed which could compete directly with our product candidates,
      significantly reducing our potential revenue stream.





*Overhead
                Costs.*The Company estimates that our overhead costs over the next two years
                will
                amount to approximately three million dollars, categorized as
                follows:




·
            
            Approximately
                $900,000 for administrative expenses including salaries, office rent
                and
                maintenance;




·
            
            Approximately
                $1,000,000 in marketing, legal and other expenses, including trademark
                filling fees, financing costs and professional fees.





·
            
            Approximately
                $1,100,000 in marketing/ promotions/sponsorships.




**Critical
      Accounting Policies**





Stock
      Based Compensation





In
      December 2004, the FASB issued a revision of SFAS No. 123 ("SFAS No. 123(R)")
      that requires compensation costs related to share-based payment transactions
      to
      be recognized in the statement of operations. With limited exceptions, the
      amount of compensation cost will be measured based on the grant-date fair value
      of the equity or liability instruments issued. In addition, liability awards
      will be re-measured each reporting period. Compensation cost will be recognized
      over the period that an employee provides service in exchange for the award.
      SFAS No. 123(R) replaces SFAS No. 123 and is effective as of the beginning
      of
      January 1, 2006. Based on the number of shares and awards outstanding as of
      December 31, 2005 (and without giving effect to any awards which may be granted
      in 2006), we do not expect our adoption of SFAS No. 123(R) in January 2006
      to
      have a material impact on the financial statements.




10





FSP
      FAS
      123(R)-5 was issued on October 10, 2006. The FSP provides that instruments
      that
      were originally issued as employee compensation and then modified, and that
      modification is made to the terms of the instrument solely to reflect an equity
      restructuring that occurs when the holders are no longer employees, then no
      change in the recognition or the measurement (due to a change in classification)
      of those instruments will result if both of the following conditions are met:
      (a). There is no increase in fair value of the award (or the ratio of intrinsic
      value to the exercise price of the award is preserved, that is, the holder
      is
      made whole), or the antidilution provision is not added to the terms of the
      award in contemplation of an equity restructuring; and (b). All holders of
      the
      same class of equity instruments (for example, stock options) are treated in
      the
      same manner. The provisions in this FSP shall be applied in the first reporting
      period beginning after the date the FSP is posted to the FASB website. The
      Company has adopted SP FAS 123(R)-5 but it did not have a material impact on
      its
      consolidated results of operations and financial condition.




Accounting
      Policies and Estimates





The
      preparation of our financial statements in conformity with accounting principles
      generally accepted in the United States of America requires our management
      to
      make certain estimates and assumptions that affect the reported amounts of
      assets and liabilities and disclosure of contingent assets and liabilities
      at
      the date of the financial statements and the reported amounts of revenues and
      expenses during the reporting period. Our
      management periodically evaluates the estimates and judgments made. Management
      bases its estimates and judgments on historical experience and on various
      factors that are believed to be reasonable under the circumstances. Actual
      results may differ from these estimates as a result of different assumptions
      or
      conditions. As
      such,
      in accordance with the use of accounting principles generally accepted in the
      United States of America, our actual realized results may differ from
      management’s initial estimates as reported. A summary of significant accounting
      policies are detailed in notes to the financial statements which are an integral
      component of this filing.





Revenue
      Recognition





The
      Company has adopted the Securities and Exchange Commission’s Staff Accounting
      Bulletin (SAB) No. 104, which provides guidance on the recognition, presentation
      and disclosure of revenue in financial statements. ****




11





The
      following financial data should be read in conjunction with the financial
      statements of Bond and related notes and other financial information appearing
      elsewhere in this report.


Statement
                  of Operations DataYears
                  Ended Decemer 31,
              
              Years
                  Ended December 31,
              
              For
                      periods
                    July
                      26, 2005
                    to
                      December 31,2007
              
              2006
              
              2006Revenues
              
              $
              11,530
              
              $
              9,414
              
              $
              20,944Cost
                  of Goods Sold
              
              
              7,845
              
              
              8,318
              
              
              16,163Operating
                  and Other Expenses
              
              
              3,965,287
              
              
              650,804
              
              
              4,781,396Net
                  Loss
              
              $
              (3,961,602
              )
              $
              (649,708
              )
              $
              (4,776,615
              )
  Years
                  Ended Decemer 31,
              
              Years
                  Ended Decemer 31,2007
              
              2006Balance
                  Sheet Data:Current
                  Assets
              
              $
              1,219,256
              
              $
              60,753Total
                  Assets
              
              
              1,314,960
              
              
              125,317Current
                  Liabilities
              
              
              30,253
              
              
              229,500Non
                  Current Liabilities
              
              
              -
              
              
              611,289Total
                  Liabilities
              
              
              30,253
              
              
              840,789Working
                  Capital (Deficit)
              
              
              1,189,003
              
              
              (168,747
              )Shareholders'Equity
                  (Deficit)
              
              $
              1,284,707
              
              $
              (715,473
              )




The
      Company has declared no common stock dividends since its inception.




**Results
      of operations**





***Fiscal
      Year End December 31, 2007, Compared to December 31,
      2006***




We
      are a
      development stage company and have generated limited revenues from sales of
      our
      first product, Fusion. For the years ended December 31, 2007 we generated
      $11,530 and $9,414 for year ended December 31, 2006. Our future revenue plan
      is
      uncertain and is depended on our ability to effectively introduce our products
      to our target consumers, generate sales and obtain contract manufacturing
      opportunities.




The
      Company incurred losses of approximately $3,961,602, and $649,708 for the year
      ended December 31, 2007 and 2006, respectively. Our losses since our inception
      through December 31, 2007 amounted to $4,776,615. The increase in the loss
      from
      2007 to 2006 reflects our investment in product development, packaging, contract
      manufacturing and marketing. General and administrative were $3,450,557 and
      $509,251 for the year ended December 31, 2007 and 2006, respectively a 15%
      increase. The increase in general and administrative expense for the periods
      relates to employ full time personnel, increased cost of being a public company,
      and the increase of the use of consulting firms.




Sales
      and
      marketing expense was $197,736 and $37,000 for the years ended December 31,
      2007
      and 2006 respectively, a 19% increase. The increase in sales and marketing
      services for the periods relates to costs associated with hiring investor
      relation firms, marketing firms, and stock related services as well as increased
      travel to promote the sales of our products.




Depreciation
      and amortization expense was $14,596 and $1,575 for the years ended December
      31,
      2007 and 2006 respectively, a 7% increase. The increase in depreciation for
      the
      periods relates to the purchase of new equipment to prepare our product
      associated with our new marketing plan.




12




Research
      and development expense was $272,469 and $82,454 for the years ended December
      31, 2007 and 2006 respectively, a 43% increase. The increase in research and
      development for the periods relates to increase in our business model to develop
      and produce our products for consumption and sales to the general public for
      increase healthiness and energy.




The
      Company incurred losses of $3,961,602 and $649,708 for the years ended December
      31, 2007 and 2006 respectively.




**Liquidity
      and Capital Resources**




The
      Company has maintained a minimum of three months of working capital in the
      bank
      since September of 2005. This figure was determined to allow for an adequate
      amount of time to secure additional funds from investors as needed. To date,
      the
      Company has succeeded in securing capital as needed, but there is no guarantee
      this will continue. As of December, 2007, the required amount was approximately
      $125,000. The company had a balance of $590,197 in its bank account at the
      end
      of December, 2007. Because the Company continues to rely upon private investors
      for additional capital to grow the business, it can not and will not accept
      trade credit from any vendors. All significant purchases are pre-paid or a
      50%
      deposit is made with the balance available in the bank account.




We
      believe we will have to rely on public and private equity and debt financings
      to
      fund our liquidity requirements over the intermediate term. We may be unable
      to
      obtain any required additional financings on terms favorable to us or at all.
      If
      adequate funds are not available on acceptable terms, and if cash and cash
      equivalents together with any income generated from operations fall short of
      our
      liquidity requirements, we may be unable to sustain operations. Continued
      negative cash flows could create substantial doubt regarding our ability to
      fully implement our business plan and could render us unable to expand our
      operations, successfully promote our brand, develop our products and respond
      to
      competitive pressures or take advantage of acquisition opportunities, any of
      which may have a material adverse effect on our business. If we raise additional
      funds through the issuance of equity securities, our stockholders may experience
      dilution of their ownership interest, and the newly issued securities may have
      rights superior to those of our common stock. If we raise additional funds
      by
      issuing debt, we may be subject to limitations on our operations, including
      limitations on the payments of dividends





The
      Company’s operating activities used $1,413,547 and $389,197 for the years ended
      December 312, 2007 and 2006 respectively. The increase in operating activities
      is the increase in the issuance common stock for consultants and the increase
      in
      our operating requirements.





Cash
      used
      by investing activities was $43,009 and $66,139 for the years ended December
      31,
      2007 and 2006 respectively. The increase is due to an increase in the purchase
      of equipment to develop our products.





Cash
      provided by financing activities was $1,986,000 and $480,780 for the years
      ended
      December 31, 2007 and 2006 respectively. The increase is due to the increase
      in
      raising funds through the sale of our common stock to develop our products
      for
      the sale in the market.





**Other
      Considerations**





There
      are
      numerous factors that affect the business and the results of its operations.
      Sources of these factors include general economic and business conditions,
      federal and state regulation of business activities, the level of demand for
      product services, the level and intensity of competition in the health drink
      industry, and the ability to develop new services based on new or evolving
      technology and the market's acceptance of those new services, the Company’s
      ability to timely and effectively manage periodic product transitions, the
      services, customer and geographic sales mix of any particular period, and our
      ability to continue to improve our infrastructure including personnel and
      systems to keep pace with the Company’s anticipated rapid growth.




13





**ITEM
      7. FINANCIAL STATEMENTS**





**BOND
      LABORATORIES, INC.**


TABLE
                  OF CONTENTS
              
              PageREPORT
                  OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
              
              F-2CONSOLIDATED
                  FINANCIAL STATEMENTS: Balance Sheet at December 31, 2007
              
              F-3Statements
                  of Operations for the years ended December 31, 2007 and
                  2006
              
              F-4And
                  for period from July 26, 2005 (inception) to December 31,
                  2007Statements
                  of Stockholders’ Equity for the years endedDecember
                  31, 2007 and 2006
              
              F-5And
                  for period from July 26, 2005 (inception) to December 31,
                  2007Statements
                  of Cash Flows for the years ended December 31, 2007 and
                  2006
              
              F-6And
                  for period from July 26, 2005 (inception) to December 31,
                  2007NOTES
                  TO FINANCIAL STATEMENTS
              
              F-7




14









REPORT
      OF
      INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM




To
      the
      Board of Directors and Stockholders of


BOND
      LABORATORIES, INC.





We
      have
      audited the accompanying balance sheet of Bond Laboratories, Inc. (A Development
      Stage Company) as of December 31, 2007 and the related statements of operations,
      changes in shareholders' deficit and cash flows for the years then ended
      December 31, 2007 and 2006 and for period from July 26, 2005 (inception) through
      December 31, 2007. These financial statements are the responsibility of the
      Company's management. Our responsibility is to express an opinion on these
      financial statements based on our audits.





We
      conducted our audit in accordance with the standards of the Public Company
      Accounting Oversight Board (United States). Those standards require that we
      plan
      and perform the audit to obtain reasonable assurance about whether the financial
      statements are free of material misstatement. An audit includes examining,
      on a
      test basis, evidence supporting the amounts and disclosures in the financial
      statements. An audit also includes assessing the accounting principles used
      and
      significant estimates made by management, as well as evaluating the overall
      financial statement presentation. We believe that our audits provided a
      reasonable basis for our opinion.





In
      our
      opinion, the financial statements referred to above present fairly, in all
      material respects, the financial position of Bond Laboratories, Inc. (A
      Development Stage Company) as of December 31, 2007, and the results of their
      operations and its cash flows for the periods then ended December 31, 2007
      from
      July 26, 2005 (inception) through December 31, 2007 in conformity with
      accounting principles generally accepted in the United States of
      America.





These
      financial statements have been prepared assuming that the Company will continue
      as a going concern. As discussed in Note 2 to the financial statements, the
      Company has operating and liquidity concerns, has incurred in a net losses
      approximately $4,776,615 during the period July 26, 2005 (inception) through
      December 31, 2007. These factors raise substantial doubt about the ability
      of
      the Company to continue as a going concern. The financial statements do not
      include any adjustments that might result from the outcome of these
      uncertainties. In this regard, Management is proposing to raise any necessary
      additional funds through loans and additional sales of its common stock. There
      are no assurances that the Company will be successful in raising additional
      capital.








JEWETT,
      SCHWARTZ, WOLFE & ASSOCIATES


Hollywood,
      Florida


March
      4,
      2008





2514
      HOLLYWOOD BOULEVARD, SUITE 508 ● HOLLYWOOD, FLORIDA 33020 ● TELEPHONE (954)
      922-5885 ● FAX (954) 922-5957


MEMBER
      -
      AMERICAN INSTITUTE OF CERTIFIED PUBLIC ACCOUNTANTS ● FLORIDA INSTITUTE OF
      CERTIFIED PUBLIC ACCOUNTANTS


PRIVATE
      COMPANIES PRACTICE SECTION OF THE AICPA ● REGISTERED WITH THE PUBLIC COMPANY
      ACCOUNTING OVERSIGHT BOARD OF THE SEC




F-2




**BOND
                  LABORATORIES, INC.****(A
                  Development Stage Company)****BALANCE
                  SHEET**
  **December
                  31****2007**ASSETS:CURRENT
                  ASSETSCash
              
              $
              590,197Accounts
                  receivables - net
              
              
              4,532Prepaid
                  expense
              
              
              624,527Total
                  current assets
              
              
              1,219,256PROPERTY
                  AND EQUIPMENT, net
              
              
              92,977Deposit
              
              
              2,727TOTAL
                  ASSETS
              
              $
              1,314,960LIABILITIES
                  AND STOCKHOLDERS' EQUITY:CURRENT
                  LIABILITIES:Accounts
                  payable
              
              $
              30,000Accrued
                  expenses and other liabilities
              
              
              253Total
                  current liabilities
              
              
              30,253Total
                  liabilities
              
              
              30,253COMMITMENTS
                  AND CONTINGENCIES
              
              
              -STOCKHOLDERS'
                  EQUITY:Preferred
                  stock, $.01 par value, 10,000,000 shares authorized;5,000,000
                  issued and outstanding
              
              
              50,000Common
                  stock, $.01 par value, 75,000,000 shares authorized;20,231,450
                  issued and outstanding as of December 31, 2007
              
              
              202,314Additional
                  paid-in capital
              
              
              5,809,008Accumulated
                  deficit during this development stage
              
              
              (4,776,615
              )Total
                  stockholders' equity
              
              
              1,284,707TOTAL
                  LIABILITIES AND STOCKHOLDERS' EQUITY
              
              $
              1,314,960The
                  accompanying notes are an integral part of these financial
                  statements.
  F-3
  **BOND
                    LABORATORIES, INC.****(A
                    Development Stage Company)****STATEMENT
                    OF OPERATIONS****FOR
                    THE YEAR ENDED DECEMBER 31, 2007 AND 2006****AND
                    FOR THE PERIOD FROM JULY 26, 2005 (INCEPTION) THROUGH DECEMBER
                    31,
                    2007**
  **For
                    the Period****from
                    July 26, 2005****(inception)
                    through****2007**
                
                **2006**
                
                **December
                    31, 2007**REVENUES:Revenues
                
                $
                11,530
                
                $
                9,414
                
                $
                20,944COST
                    OF GOOD SOLD
                
                
                7,845
                
                
                8,318
                
                
                16,163GROSS
                    PROFIT
                
                
                3,685
                
                
                1,096
                
                
                4,781OPERATING
                    EXPENSES:General
                    and administrative expenses
                
                
                3,450,557
                
                
                509,251
                
                
                4,103,841Sales
                    and marketing expenses
                
                
                197,736
                
                
                37,000
                
                
                241,822Depreciation
                    and amortization
                
                
                14,596
                
                
                1,575
                
                
                16,171Research
                    and development
                
                
                272,469
                
                
                82,454
                
                
                366,846Total
                    operating expenses
                
                
                3,935,358
                
                
                630,280
                
                
                4,728,680OPERATING
                    LOSS
                
                
                (3,931,673
                )
                
                (629,184
                )
                
                (4,723,899
                )OTHER
                    (INCOME) AND EXPENSES:Interest
                    expense
                
                
                42,631
                
                
                22,296
                
                
                67,190Interest
                    Income
                
                
                (6,702
                )
                
                (1,772
                )
                
                (8,474
                )Rental
                    income
                
                
                (6,000
                )
                
                -
                
                
                (6,000
                )Total
                    other expense
                
                
                29,929
                
                
                20,524
                
                
                52,716NET
                    LOSS
                
                $
                (3,961,602
                )
                $
                (649,708
                )
                $
                (4,776,615
                )NET
                    LOSS PER SHARE:Basic
                
                $
                (0.43
                )
                $
                (0.39
                )Diluted
                
                $
                (0.38
                )
                $
                (0.39
                )Basic
                
                
                9,131,404
                
                
                1,657,189Diluted
                
                
                10,370,004
                
                
                1,657,189The
                    accompanying notes are an integral part of these financial
                    statements.
  F-4
  **BOND
                    LABORATORIES, INC.****(
                    A Development Stage Company)****STATEMENT
                    OF STOCKHOLDER' EQUITY (DEFICIENCY)****FOR
                    THE YEARS ENDED DECEMBER 31, 2007 AND 2006****AND
                    FOR THE PERIOD FROM JULY 26, 2005 (INCEPTION) THROUGH DECEMBER
                    31,
                    2007**
  **Common
                    Stock**
                
                **Preferred
                    Stock**
                
                
                
                **Additional
                      **Paid-in****
                
                **Accumulated****Shares**
                
                **Amount**
                
                **Shares**
                
                **Amount**
                
                **Capital**
                
                **Deficit**
                
                **Total**JULY
                    26, 2005
                
                
                2,000
                
                $
                20
                
                
                -
                
                $
                -
                
                $
                -
                
                $
                -
                
                $
                20Net
                    loss
                
                
                -
                
                
                -
                
                
                -
                
                
                -
                
                
                -
                
                
                (165,305
                )
                
                (165,305
                )DECEMBER
                    31, 2005
                
                
                2,000
                
                $
                20
                
                
                -
                
                $
                -
                
                $
                -
                
                $
                (165,305
                )
                $
                (165,285
                )Common
                    stock issued for compensation
                
                
                4,952,000
                
                
                49,520
                
                
                -
                
                
                -
                
                
                -
                
                
                -
                
                
                49,520Preferred
                    stock issued for compensation
                
                
                -
                
                
                -
                
                
                5,000,000
                
                
                50,000
                
                
                -
                
                
                -
                
                
                50,000Net
                    loss
                
                
                -
                
                
                -
                
                
                -
                
                
                -
                
                
                -
                
                
                (649,708
                )
                
                (649,708
                )DECEMBER
                    31, 2006
                
                
                4,954,000
                
                $
                49,540
                
                
                5,000,000
                
                $
                50,000
                
                $
                -
                
                $
                (815,013
                )
                $
                (715,473
                )Common
                    stock issued for compensation
                
                
                2,117,625
                
                
                21,176
                
                
                -
                
                
                -
                
                
                2,488,301
                
                
                -
                
                
                2,509,477Common
                    stock issued for prepaid services
                
                
                200,000
                
                
                2,000
                
                
                
                
                
                
                
                
                598,000
                
                
                
                
                
                600,000Common
                    stock issued issued for accrued liabilities
                
                
                400,000
                
                
                4,000
                
                
                
                
                
                
                
                
                226,000
                
                
                
                
                
                230,000Common
                    stock issued for cash
                
                
                2,014,000
                
                
                20,140
                
                
                -
                
                
                -
                
                
                1,630,860
                
                
                -
                
                
                1,651,000Common
                    stock issued in a 2 for 1 forward split
                
                
                9,067,225
                
                
                90,672
                
                
                -
                
                
                -
                
                
                (90,672
                )
                
                -
                
                
                -Common
                    stock issued for convertible notes principal and interest expense
                
                
                1,478,600
                
                
                14,786
                
                
                -
                
                
                -
                
                
                944,133
                
                
                -
                
                
                958,919Warrants
                    issued
                
                
                -
                
                
                -
                
                
                -
                
                
                -
                
                
                12,386
                
                
                -
                
                
                12,386Net
                    loss
                
                
                -
                
                
                -
                
                
                -
                
                
                -
                
                
                -
                
                
                (3,961,602
                )
                
                (3,961,602
                )DECEMBER
                    31, 2007
                
                
                20,231,450
                
                $
                202,314
                
                
                5,000,000
                
                $
                50,000
                
                $
                5,809,008
                
                $
                (4,776,615
                )
                $
                1,284,707The
                    accompanying notes are an integral part of these financial
                    statements.
  F-5
  **BOND
                    LABORATORIES, INC.****(
                    A Development Stage Company)****STATEMENTS
                    OF CASH FLOWS****FOR
                    THE YEARS ENDED DECEMBER 31, 2007 AND 2006****AND
                    FOR THE PERIOD FROM JULY 26, 2005 (INCEPTION) THROUGH DECEMBER
                    31,
                    2007**
  **For
                    the Period****from
                    July 26, 2005****(inception)
                    to****2007**
                
                **2006**
                
                **December
                    31, 2007**CASH
                    FLOWS FROM OPERATING ACTIVITIES:Net
                    Loss
                
                $
                (3,961,602
                )
                $
                (649,708
                )
                $
                (4,776,615
                )Adjustments
                    to reconcile net loss to net cash(used
                    in) operating activities:Depreciation
                    and amortization
                
                
                14,596
                
                
                1,575
                
                
                16,171Common
                    stock issued in lieu of interest expense
                
                
                26,625
                
                
                -
                
                
                26,625Warrants
                    issued in conversion of debt
                
                
                12,386
                
                
                -
                
                
                12,386Preferred
                    stock issued for services
                
                
                -
                
                
                50,000
                
                
                50,000Common
                    stock issued for compensation
                
                
                2,509,477
                
                
                49,520
                
                
                2,789,017Changes
                    in assets and liabilities:Accounts
                    receivables
                
                
                (4,532
                )
                
                
                
                
                (4,532
                )Prepaid
                    expenses
                
                
                (24,527
                )
                
                -
                
                
                (24,527
                )Deposits
                
                
                (2,727
                )
                
                -
                
                
                (2,727
                )Accounts
                    payable
                
                
                15,500
                
                
                10,420
                
                
                30,000Accrued
                    liabilities
                
                
                15,253
                
                
                135,000
                
                
                253Accrued
                    interest
                
                
                (13,996
                )
                
                13,996
                
                
                -Net
                    cash used in operating activities
                
                
                (1,413,547
                )
                
                (389,197
                )
                
                (1,883,949
                )CASH
                    FLOWS FROM INVESTING ACTIVITIES:Purchase
                    of Intangible Asset
                
                
                (43,009
                )
                
                (66,139
                )
                
                (109,148
                )Net
                    cash used in investing activities
                
                
                (43,009
                )
                
                (66,139
                )
                
                (109,148
                )CASH
                    FLOWS FROM FINANCING ACTIVITIES:Proceeds
                    from the issuance of common stock
                
                
                1,651,000
                
                
                -
                
                
                1,651,000Proceeds
                    from convertible notes payables
                
                
                335,000
                
                
                480,000
                
                
                815,000Proceeds
                    from loans affiliates
                
                
                -
                
                
                780
                
                
                117,294Net
                    cash provided by financing activities
                
                
                1,986,000
                
                
                480,780
                
                
                2,583,294INCREASE
                    IN CASH
                
                
                529,444
                
                
                25,444
                
                
                590,197CASH,
                    BEGINNING OF YEAR
                
                
                60,753
                
                
                35,309
                
                
                -CASH,
                    END OF YEAR
                
                $
                590,197
                
                $
                60,753
                
                $
                590,197**SUPPLEMENTAL
                    CASH FLOW INFORMATION:**Conversion
                    of debt into common shares
                
                $
                815,000
                
                $
                -
                
                $
                815,000Issuance
                    of stock for repayment of loan affiliates
                
                $
                117,294
                
                $
                -
                
                $
                117,294Issuance
                    of common stock for prepaid services
                
                $
                600,000
                
                $
                -
                
                $
                600,000Issuance
                    of common stock for accrued liabilities
                
                $
                230,000
                
                $
                -
                
                $
                230,000The
                    accompanying notes are an integral part of these financial
                    statements.
  F-6




**BOND
      LABORATORIES, INC.**


**Development
      Stage Company**


**NOTES
      TO FINANCIAL STATEMENTS**


**FOR
      THE YEARS ENDED DECEMBER 31, 2007 AND 2006**


**AND
      FOR PERIOD FROM JULY 26, 2005 (INCEPTION) THROUGH DECEMBER 31,
      2007**





NOTE
      1 -
      DESCRIPTION OF BUSINESS





Bond
      Laboratories, Inc. (“The Company”) was incorporated in the state of Nevada on
      July 26, 2005. The Company is a development stage company researching and
      developing energy drinks. Bond Laboratories is building a turn-key Nutraceutical
      Dietary Supplement business catering to all five of the distribution segments
      focusing on the three major categories of the industry; Energy, Pain Relief
      and
      Weight loss, utilizing a state of the art, alternative delivery method vs.
      antiquated capsules and pills.





NOTE
      2 -
      GOING CONCERN ISSUES





The
      accompanying financial statements have been prepared in conformity with
      accounting principles generally accepted in the United States of America which
      contemplate continuation of the Company as a going concern. However, the Company
      has year end losses from operations and had minimal revenues from operations
      in
      2007 and 2006. From inception through the year ended December 31, 2007, the
      Company has accumulated net losses of $4,776,615. Further, the Company has
      inadequate working capital to maintain or develop its operations, and is
      dependent upon funds from private investors and the support of certain
      stockholders.





These
      factors raise substantial doubt about the ability of the Company to continue
      as
      a going concern. The financial statements do not include any adjustments that
      might result from the outcome of these uncertainties. In this regard, Management
      is planning to raise any necessary additional funds through loans and additional
      sales of its common stock. There is no assurance that the Company will be
      successful in raising additional capital.





NOTE
      3 -
      SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES





The
      Company prepares its financial statements in accordance with accounting
      principles generally accepted in the United States of
      America.  Significant accounting policies are as follows:





Basis
      of Presentation





The
      Company has produced minimal revenue from its principal business and is a
      development stage company as defined by the Statement of Financial Accounting
      Standards (SFAS) No. 7 “Accounting and Reporting by Development State
      Enterprises”.





Use
      of
      Estimates





The
      preparation of financial statements in conformity with accounting principles
      generally accepted in the United States of America requires management to make
      estimates and assumptions that affect the reported amounts of assets and
      liabilities and disclosure of contingent assets and liabilities at the date
      of
      the financial statements.  These estimates and assumptions also affect
      the reported amounts of revenues, costs and expenses during the reporting
      period.  Management evaluates these estimates and assumptions on a
      regular basis.  Actual results could differ from those
      estimates.




These
      estimates and assumptions also affect the reported amounts of revenues, costs
      and expenses during the reporting period.  Management evaluates these
      estimates and assumptions on a regular basis.  Actual results could
      differ from those estimates.





F-7




Revenue
      Recognition





Revenue
      includes product sales. The Company recognizes revenue from product sales in
      accordance with Staff Accounting Bulletin (SAB) No. 104, “Revenue Recognition in
      Financial Statement” which is at the time customers are invoiced at shipping
      point, provided title and risk of loss has passed to the customer, evidence
      of
      an arrangement exists, fees are contractually fixed or determinable, collection
      is reasonably assured through historical collection results and regular credit
      evaluations, and there are no uncertainties regarding customer acceptance.





Advertising
      Costs





All
      advertising costs are charged to expense as incurred. Advertising expense for
      the years ended December 31, 2007 and 2006 was approximately
      $45,000 and $600, respectively.





Accounts
      Receivable





Substantially
      all of the Company’s accounts receivable balance is relate to trade receivables.
      Trade accounts receivable are recorded at the invoiced amount and do not bear
      interest. The allowance for doubtful accounts is the Company’s best estimate of
      the amount of probable credit losses in its existing accounts receivable. The
      Company will maintain allowances for doubtful accounts for estimated losses
      resulting from the inability of its customers to make required payments for
      products. Accounts with known financial issues are first reviewed and specific
      estimates are recorded. The remaining accounts receivable balances are then
      grouped in categories by the amount of days the balance is past due, and the
      estimated loss is calculated as a percentage of the total category based upon
      past history. Account balances are charged off against the allowance when it
      is
      probable the receivable will not be recovered. No allowance for doubtful
      accounts and bad debts were written off in December 31, 2007 and 2006 as the
      Company was a development stage company.





Cash
      and Cash Equivalents





The
      Company considers all highly liquid investments with an original maturity of
      three months or less to be cash equivalents.  At December 31, 2007,
      cash and cash equivalents include cash on hand and cash in the
      bank.





Research
      and Development





Costs
      are
      expensed as incurred.  There was $272,469 in research and development
      expense for year ended December 31, 2007 as compared to $82,454 for year ended
      December 31, 2006.





Property
      and Equipment





Property
      and equipment is recorded at cost and depreciated over the estimated useful
      lives of the assets using principally the straight-line method. When items
      are
      retired or otherwise disposed of, income is charged or credited for the
      difference between net book value and proceeds realized. Ordinary maintenance
      and repairs are charged to expense as incurred, and replacements and betterments
      are capitalized.





The
      range
      of estimated useful lives used to calculated depreciation for principal items
      of
      property and equipment are as follow:





Asset
                Category
            
            Depreciation/
              Amortization
                PeriodFurniture
                and Fixture
            
            3
                YearsOffice
                equipment
            
            3
                YearsLeasehold
                improvements
            
            5
                Years





F-8





Impairment
      of Long-Lived Assets





In
      accordance with SFAS No. 144, long-lived assets, such as property, plant, and
      equipment, and purchased intangibles, are reviewed for impairment whenever
      events or changes in circumstances indicate that the carrying amount of an
      asset
      may not be recoverable. Goodwill and other intangible assets are tested for
      impairment. Recoverability of assets to be held and used is measured by a
      comparison of the carrying amount of an asset to estimated undiscounted future
      cash flows expected to be generated by the asset. If the carrying amount of
      an
      asset exceeds its estimated future cash flows, an impairment charge is
      recognized by the amount by which the carrying amount of the asset exceeds
      the
      fair value of the asset. There were no events or changes in circumstances that
      necessitated an impairment of long lived assets.





Income
      Taxes





Deferred
      income taxes are provided based on the provisions of SFAS No. 109, "Accounting
      for Income Taxes" ("SFAS No. 109"), to reflect the tax consequences in future
      years of differences between the tax bases of assets and liabilities and their
      financial reporting amounts based on enacted tax laws and statutory tax rates
      applicable to the periods in which the differences are expected to affect
      taxable income. Valuation allowances are established when necessary to reduce
      deferred tax assets to the amount expected to be realized.





Concentration
      of Credit Risk





The
      Company maintains its operating cash balances in banks in Solano Beach,
      California. The Federal Depository Insurance Corporation (FDIC) insures accounts
      at each institution up to $100,000.





Earnings
      Per Share




Basic
      earnings per share is computed by dividing net income (loss) available to common
      shareholders by the weighted average number of common shares outstanding during
      the reporting period. Diluted earnings per share reflects the potential dilution
      that could occur if stock options and other commitments to issue common stock
      were exercised or equity awards vest resulting in the issuance of common stock
      that could share in the earnings of the Company.  As of December 31,
      2007, there were no potential dilutive instruments that could result in share
      dilution.





Fair
      Value of Financial Instruments




The
      fair
      value of a financial instrument is the amount at which the instrument could
      be
      exchanged in a current transaction between willing parties other than in a
      forced sale or liquidation.





The
      carrying amounts of the Company’s financial instruments, including cash,
      accounts payable and accrued liabilities, income tax payable and related party
      payable approximate fair value due to their most maturities.





Recent
      Accounting Pronouncements




Recent
      accounting pronouncements that the Company has adopted or will be required
      to
      adopt in the future are summarized below.




On
      December 21, 2007 the Securities and Exchange Commission staff issued Staff
      Accounting Bulletin No. 110 (SAB 110), which, effective January 1, 2008, amends
      and replaces SAB 107, Share-Based Payment. SAB 110 expresses the views of the
      SEC staff regarding the use of a "simplified" method in developing an estimate
      of expected term of "plain vanilla" share options in accordance with FASB
      Statement No. 123(R), Share-Based Payment. Under the "simplified" method, the
      expected term is calculated as the midpoint between the vesting date and the
      end
      of the contractual term of the option. The use of the "simplified" method,
      which
      was first described in Staff Accounting Bulletin No. 107, was scheduled to
      expire on December 31, 2007. SAB 110 extends the use of the "simplified" method
      for "plain vanilla" awards in certain situations. The SEC staff does not expect
      the "simplified" method to be used when sufficient information regarding
      exercise behavior, such as historical exercise data or exercise information
      from
      external sources, becomes available. The Company is currently evaluating the
      potential impact that the adoption of SAB 110 could have on its financial
      statements.




F-9





In
      December 2007, the FASB issued SFAS No. 141(R), “Business Combinations”. This
      Statement replaces SFAS No. 141, Business Combinations, and requires an acquirer
      to recognize the assets acquired, the liabilities assumed, including those
      arising from contractual contingencies, any contingent consideration, and any
      noncontrolling interest in the acquiree at the acquisition date, measured at
      their fair values as of that date, with limited exceptions specified in the
      statement. SFAS No. 141(R) also requires the acquirer in a business combination
      achieved in stages (sometimes referred to as a step acquisition) to recognize
      the identifiable assets and liabilities, as well as the noncontrolling interest
      in the acquiree, at the full amounts of their fair values (or other amounts
      determined in accordance with SFAS No. 141(R)). In addition, SFAS No. 141(R)'s
      requirement to measure the noncontrolling interest in the acquiree at fair
      value
      will result in recognizing the goodwill attributable to the noncontrolling
      interest in addition to that attributable to the acquirer. SFAS No. 141(R)
      amends SFAS No. 109, Accounting for Income Taxes, to require the acquirer to
      recognize changes in the amount of its deferred tax benefits that are
      recognizable because of a business combination either in income from continuing
      operations in the period of the combination or directly in contributed capital,
      depending on the circumstances. It also amends SFAS No. 142, Goodwill and Other
      Intangible Assets, to, among other things, provide guidance on the impairment
      testing of acquired research and development intangible assets and assets that
      the acquirer intends not to use. SFAS No. 141(R) applies prospectively to
      business combinations for which the acquisition date is on or after the
      beginning of the first annual reporting period beginning on or after December
      15, 2008. The Company is currently evaluating the potential impact that the
      adoption of SFAS No. 141(R) could have on its financial statements.





In
      December 2007, the FASB issued SFAS No. 160, “Noncontrolling Interests in
      Consolidated Financial Statements” (“SFAS No. 160”), which amends Accounting
      Research Bulletin 51, Consolidated Financial Statements, to establish accounting
      and reporting standards for the noncontrolling interest in a subsidiary and
      for
      the deconsolidation of a subsidiary. It also clarifies that anoncontrolling
      interest in a subsidiary is an ownership interest in the consolidated entity
      that should be reported as equity in the consolidated financial statements.
      SFAS
      No. 160 also changes the way the consolidated income statement is presented
      by
      requiring consolidated net income to be reported at amounts that include the
      amounts attributable to both the parent and the noncontrolling interest. It
      also
      requires disclosure, on the face of the consolidated statement of income, of
      the
      amounts of consolidated net income attributable to the parent and to the
      noncontrolling interest. SFAS No. 160 requires that a parent recognize a gain
      or
      loss in net income when a subsidiary is deconsolidated and requires expanded
      disclosures in the consolidated financial statements that clearly identify
      and
      distinguish between the interests of the parent owners and the interests of
      the
      noncontrolling owners of a subsidiary. SFAS No. 160 is effective for fiscal
      periods, and interim periods within those fiscal years, beginning on or after
      December 15, 2008. The Company does not expect the adoption of SFAS No. 160
      to
      have a material impact on its financial statements.




In
      February 2007, the FASB issued SFAS No. 159, “The Fair Value Option
      for Financial Assets and Financial Liabilities” ** (“SFAS
      No. 159”), which provides companies with an option to report selected
      financial assets and liabilities at fair value with the changes in fair value
      recognized in earnings at each subsequent reporting date. SFAS No. 159
      provides an opportunity to mitigate potential volatility in earnings caused
      by
      measuring related assets and liabilities differently, and it may reduce the
      need
      for applying complex hedge accounting provisions. If elected, SFAS No. 159
      is effective for fiscal years beginning after November 15, 2007. Management
      is currently evaluating the impact that this statement may have on the Company
      results of operations and financial position, and has yet to make a decision
      on
      the elective adoption of SFAS No. 159.





In
      September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements" (SFAS
      No. 157). SFAS No. 157 provides guidance for using fair value to measure assets
      and liabilities. SFAS No. 157 addresses the requests from investors for expanded
      disclosure about the extent to which companies measure assets and liabilities
      at
      fair value, the information used to measure fair value and the effect of fair
      value measurements on earnings. SFAS No. 157 applies whenever other standards
      require (or permit) assets or liabilities to be measured at fair value, and
      does
      not expand the use of fair value in any new circumstances. SFAS No. 157 is
      effective for financial statements issued for fiscal years beginning after
      November 15, 2007 and will be adopted by the Company in the first quarter of
      fiscal year 2009. The Company is unable at this time to determine the effect
      that its adoption of SFAS No. 157 will have on its results of operations and
      financial condition.




F-10







In
      July
      2006, the FASB issued FASB Interpretation No. 48, "Accounting for Uncertainty
      in
      Income Taxes, an interpretation of FASB Statement No. 109" (FIN 48). FIN 48
      clarifies the accounting for uncertainty in income taxes by prescribing the
      recognition threshold a tax position is required to meet before being recognized
      in the financial statements. It also provides guidance on derecognition,
      classification, interest and penalties, accounting in interim periods,
      disclosure and transition. The cumulative effects, if any, of applying FIN
      48
      will be recorded as an adjustment to retained earnings as of the beginning
      of
      the period of adoption. FIN 48 is effective for fiscal years beginning after
      December 15, 2006, and the Company is required to adopt it in the first quarter
      of fiscal year 2008. The Company is currently evaluating the effect that the
      adoption of FIN 48 will have on its results of operations and financial
      condition and is not currently in a position to determine such effects, if
      any.





In
      June
      2006, the FASB ratified Emerging Issues Task Force (EITF) Issue No. 06−3 (EITF
      06-3), “How Taxes Collected from Customers and Remitted to Governmental
      Authorities Should Be Presented in the Income Statement (That Is, Gross versus
      Net Presentation).” EITF 06−3 applies to any tax assessed by a governmental
      authority that is directly imposed on a revenue producing transaction between
      a
      seller and a customer. EITF 06−3 allows companies to present taxes either gross
      within revenue and expense or net. If taxes subject to this issue are
      significant, a company is required to disclose its accounting policy for
      presenting taxes and the amount of such taxes that are recognized on a gross
      basis. EITF 06−3 is required to be adopted during the first quarter of fiscal
      year 2008. The Company is a development stage and taxes are currently not
      material to the Company’s financial statements.





In
      October 10, 2006 FASB Staff Position issued Financial Statement Position (“FSP”)
      FAS No. 123(R)-5 “Amended of FASB Staff Position FAS 123(R)-1 “Classification
      and Measurement of Freestanding Financial Instruments Originally issued in
      Exchange of Employee Services under FASB Statement No. 123(R)”. The FAS provides
      that instruments that were originally issued as employee compensation and then
      modified, and that modifications made to the terms of the instrument solely
      to
      reflect an equity restructuring that occurs when the holders are no longer
      employees, then no change in the recognition or the measurement (due to a change
      in classification) of those instruments will result if both of the following
      conditions are met: (a). There is no increase in fair value of the award (or
      t
      he ratio of intrinsic value to the exercise price of the award is preserved,
      that is, the holder is made whole), or the antidilution provision is not added
      to the terms of the award in contemplation of an equity restructuring; and
      (b).
      All holders of the same class of equity instruments (for example, stock options)
      are treated in the same manner. The provisions in this FSP shall be applied
      in
      the first reporting period beginning after the date the FSP is posted to the
      FASB website.





NOTE
      4 -
      PREPAID EXPENSES





The
      Company has prepaid expenses as of December 31, 2007 as follows:




December
                31,2007
            
            2006Sponsorship
                Agreement
            
            $
            600,000
            
            $
            -Legal
                Retainer
            
            
            5,000
            
            
            -ProTab
                laboratories retainer
            
            
            19,527
            
            
            -Total
            
            $
            624,527
            
            $
            -





The
      Company entered into a sponsorship agreement with L&M Racing, Inc. The
      agreement calls for 200,000 common shares issued, as 144 common stock, and
      are
      earned ratably through the next 12 months. The Company issued these shares
      on
      December 27, 2007. The Company also has prepaid legal and manufacturing
      retainers which are expenses when incurred.




F-11





NOTE
      5 -
      PROPERTY AND EQUIPMENT





The
      Company has fixed assets as of December 31, 2007 and 2006 as
      follows:





December
                31,2007
            
            2006Equipment
            
            $
            109,148
            
            $
            66,139Accumulated
                depreciation
            
            
            (16,171
            )
            
            (1,575
            )Total
            
            $
            92,977
            
            $
            64,564





Depreciation
      Expense is $14,596 for December 31, 2007 compared to $1,575 for December 31,
      2006.





NOTE
      6 -
      SHARE CAPITAL





On
      July
      26, 2005, the Company authorized 75,000,000 shares of common stock, at $.01
      par
      value and as of December 31, 2007 20,431,450 common shares were issued and
      outstanding. In August 2006, the Company authorized 10,000,000 of preferred
      shares at a par value of .01 and 5,000,000 shares were issued and outstanding
      as
      of December 31, 2007.





Effective
      February 26, 2007, the Company closed the initial phase on its financing. The
      offering consisted of the sale of up to 1,000,000 units (“Units”) each Unit
      consisting of one share of the Company’s common stock and one warrant to
      purchase shares of the Company’s common stock at $3.00 per share, at a price of
      $2.00 per Unit. The Company issued 1,238,600 in warrants related to this initial
      phase financing.





The
      fair
      value of each warrant grant was estimated on the date of grant using the
      Black-Scholes option-pricing model with the following assumptions for year
      ended
      December 31, 2007:




Dividend
                yield
            
            
            NoneVolatility
            
            
            0.491Risk
                free interest rate
            
            
            4.18
            %Expected
                asset life
            
            
            5
                years




The
      Company valued the warrants using Black-Scholes option-pricing
      model.  The assumptions under Black Scholes are based on the market
      value of the stock price at the time of issuance, the exercise price of the
      warrants, life, volatility, risk free interest rate of the
      warrants.  The Black Scholes option-price model was the best
      determinable value of the warrants that the Company “knew up front” when issuing
      the warrants in accordance with EITF 96-18.  The warrants had no
      vesting schedule and could be exercised at the option of the parties receiving
      the warrants until either terminated by contract or expiration.  No
      discounts were applied to the calculation through the Black Scholes option-price
      model.”





Common
      Stock




**Year
                Ended**
            
            **Stock
                  issued**
                **for
                  Cash**
            
            **Cash
                Received**
            
            **Stock
                  issued**
                **for
                  Services**
            
            **Stock
                  issued for**
                **Debt
                  Conversion**
            
            **Stock
                  issued for**
                **Stock
                  Split**December
                31, 2007
            
            
            2,014,000
            
            $
            1,651,000
            
            
            2,317,625
            
            
            1,878,600
            
            
            9,067,225December
                31, 2006
            
            
            -
            
            
            -
            
            
            4,954,000
            
            
            -Total
                Issued
            
            
            2,014,000
            
            $
            1,651,000
            
            
            7,271,625
            
            
            1,878,600
            
            
            9,067,225




F-12




NOTE
      6 -
      SHARE CAPITAL - Continued





During
      the year ended December 31, 2007, the Company has issued shares of its common
      stock as consideration to consultants for the fair value of the services
      rendered. The value of those shares is determined based on the trading value
      of
      the stock at the dates on which the agreements were into for the services and
      the value of services rendered. During the year ended December 31, 2007, the
      Company granted to consultants, 2,717,625 shares of common stock valued in
      the
      aggregate at $3,339,477 with a strike price of par value since the Company
      was
      not trading its common stock. The stock issued for services includes $3,339,477
      of the compensation for services rendered in accordance with the consultant
      respective agreements.





During
      the year ended December 31, 2006, the Company has issued shares of its common
      stock as consideration to consultants for the fair value of the services
      rendered. The value of those shares is determined based on the trading value
      of
      the stock at the dates on which the agreements were into for the services and
      the value of services rendered. During the year ended December 31, 2006, the
      Company granted to consultants, 4,954,000 shares of common stock valued in
      the
      aggregate at $49,540 with a strike price of par value since the Company was
      not
      trading its common stock. The stock issued for services includes $49,540 of
      the
      compensation for services rendered in accordance with the consultant respective
      agreements.





During
      the year ended December 31, 2007, the Company issued 2,014,000 shares of its
      common stock for $1,651,000. The shares were issued to third parties in a
      private placement of the Company’s common stock. The shares were sold throughout
      the year ended December 31, 2007, at $.82 through $1.00 per share at the end
      of
      the year when the shares were sold.





During
      year ended December 31, 2007, the Company issued 1,238,600 shares of its common
      stock for the conversion of debt in the amount of $815,000 plus accrued interest
      of $26,625. Also the Company issued 240,000 common shares for the conversion
      of
      affiliate debt of $117,294. The Company issued 230,000 common shares for the
      conversion of debt from the accrued salary of the Company’s CEO of $230,000.





NOTE
      7 -
      INCOME TAXES





The
      provision (benefit) for income taxes from continued operations for the years
      ended December 31, 2007 and 2006 consist of the following:





December
                31,2007
            
            2006Current:Federal
            
            $
            -
            
            $
            -State
            
            
            -
            
            
            -Deferred:Federal
            
            $
            1,536,010
            
            $
            259,883State
            
            
            402,173
            
            
            64,9701,938,183
            
            
            324,853Benefit
                from the operatingloss
                carryforward
            
            
            (1,938,183
            )
            
            (324,853
            )(Benefit)
                provision for income taxes, net
            
            $
            -
            
            $
            -





F-13




NOTE
      7 -
      INCOME TAXES - Continued





The
      difference between income tax expense computed by applying the federal statutory
      corporate tax rate and actual income tax expense is as follows:





December
                31,2007
            
            2006Statutory
                federal income tax rate
            
            
            34.0
            %
            
            34.0
            %State
                income taxes and other
            
            
            8.9
            %
            
            8.9
            %Effective
                tax rate
            
            
            42.9
            %
            
            42.9
            %




Deferred
      income taxes result from temporary differences in the recognition of income
      and
      expenses for the financial reporting purposes and for tax purposes. The tax
      effect of these temporary differences representing deferred tax asset and
      liabilities result principally from the
      following:





December
                31,2007
            
            2006Net
                operating loss carryforward
            
            
            1,938,183
            
            
            324,853Valuation
                allowance
            
            
            (1,938,183
            )
            
            (324,853
            )Deferred
                income tax asset
            
            $
            -
            
            $
            -





The
      Company has a net operating loss carryforward of approximately $2,263,036
      available to offset future taxable income through 2028.





NOTE
      8 -
      COMMITMENTS AND CONTINGENCIES





The
      Company has entered into various consulting agreements with outside consultants.
      However, certain of these agreements included additional compensation on the
      basis of performance. The consulting agreement are with key shareholders that
      are instrumental to the success of the company and its development of it
      product.





NOTE
      9 -
      RELATED PARTY TRANSACTIONS





The
      Company is managed by its key shareholder. This shareholder is the sole
      shareholder of Small World Traders.





NOTE
      10 -
      NET LOSS PER SHARE





Restricted
      shares and warrants are included in the computation of the weighted average
      number of shares outstanding during the periods. The net loss per common share
      is calculated by dividing the consolidated loss by the weighted average number
      of shares outstanding during the periods.





NOTE
      11 -
      SUBSEQUENT EVENTS





The
      Company in January and February of 2008 issued 111,000 common shares for
      $111,000 in cash.





*
      * * * *
      *




F-14




**ITEM
      8.**  **CHANGES
      IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
      DISCLOSURE.**




We
      have
      had no disagreements on any matter of accounting principles or practices,
      financial statement disclosure, or auditing scope or procedures with any of
      our
      accountants for the year ended December 31, 2007.




We
      have
      not had any other changes in nor have we had any disagreements, whether or
      not
      resolved, with our accountants on accounting and financial disclosures during
      our two recent fiscal years or any later interim period.





**ITEM
      8A. CONTROLS AND PROCEDURES**




(a)
            Evaluation
                of disclosure controls and
                procedures





Based
      upon an evaluation of the effectiveness of the Company’s disclosure controls and
      procedures performed by the Company’s management, with participation of the
      Company’s Chief Executive Officer, Chief Operating Officer, and its Chief
      Accounting Officer as of the end of the period covered by this report, the
      Company’s Chief Executive Officer, Chief Operating Officer, and its Chief
      Accounting Officer concluded that the Company’s disclosure controls and
      procedures have been effective in ensuring that material information relating
      to
      the Company, including its consolidated subsidiary, is made known to the
      certifying officers by others within the Company and the Bank during the period
      covered by this report.







As
      used
      herein, “disclosure controls and procedures” mean controls and other procedures
      of the Company that are designed to ensure that information required to be
      disclosed by the Company in the reports that it files or submits under the
      Securities Exchange Act is recorded, processed, summarized and reported, within
      the time periods specified in the Commission’s rules and
      forms.  Disclosure controls and procedures include, without
      limitation, controls and procedures designed to ensure that information required
      to be disclosed by the Company in the reports that it files or submits under
      the
      Securities Exchange Act is accumulated and communicated to the Company’s
      management, including its principal executive and principal financial officers,
      or persons performing similar functions, as appropriate to allow timely
      decisions regarding required disclosure.





(b)
            Management’s
                Report on Internal Control Over Financial
                Reporting





Management
      is responsible for establishing and maintaining adequate internal control over
      financial reporting, as such term is defined in Exchange Act Rule 13a-15(f)
      under the Securities Exchange Act of 1934.  Under the supervision and
      with the participation of the Chief Executive Officer, the Chief Operating
      Officer and the Chief Accounting Officer, we conducted an evaluation of the
      effectiveness of our control over financial reporting based on the framework
      in *Internal
      Control-Integrated Framework* issued
      by
      the Committee of Sponsoring Organizations of the Treadway Commission
      (“COSO”).  Based on our evaluation under the framework, management has
      concluded that our internal control over financial reporting was effective
      as of
      December 31, 2007.





This
      annual report does not include an attestation report of the Company’s registered
      public accounting firm regarding internal control over financial
      reporting.  Management’s report was not subject to attestation by the
      Company’s registered public accounting firm pursuant to temporary rules of the
      Securities and Exchange Commission that permit the Company to provide only
      management’s report in this annual report.




15





(c)
            Changes
                in Internal Control over Financial
                Reporting





There
      have not been any changes in the Company’s internal controls or in other factors
      that occurred during the Company’s last fiscal quarter ended December 31, 2007
      that have materially affected or are reasonably likely to materially affect
      the
      Company’s internal control over financial reporting.





**ITEM
      8B. OTHER INFORMATION**





None


**PART
      III**





**ITEM
      9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS; COMPLIANCE
      WITH
      SECTION 16(a) OF THE EXCHANGE ACT.**





**Director
      and Executive Officer**





Set
      forth
      below is information regarding the Company’s current directors and executive
      officers. There are no family relationships between any of our directors or
      executive officers. The directors are elected annually by stockholders. The
      executive officers serve at the pleasure of the Board of Directors.





Name
            
            Age
            
            TitleScott
                Landow
            
            52
            
            President
                and Chief Executive Officer, Director, Principle Accounting
                OfficerEric
                Schick
            
            48
            
            President





The
      chief
      executive officer and sole director and officer of the Company will hold office
      until additional members or officers are duly elected and qualified. The
      background and principal occupations of the officers and sole director of the
      Company is as follows:





**Scott
      D. Landow** is
      our
      sole director, CEO, CFO, and Senior Managing Director of New Business
      Development since May, 2005. From December 2005 through May 2005 Mr. Landow
      was
      President, CEO and a member of the board of directors of Bridgetech Holdings
      International a publicly traded company leveraging
      significant relationships in China & the U.S. to capitalize on proprietary
      opportunities in high growth segments of the healthcare industry. From
      August 2000 through February 2005, Mr. Landow was President of Parentech Inc.,
      an emerging medical device company for newborns and infants.





**Eric
      Schick** ,
      President joined the Company in December 2006. Prior to joining Bond, Mr. Schick
      was Vice President and National Sales Manager for Natrol, an $80 million
      nutritional supplements company. From 2004 to 2005 he was Vice President and
      Chief Sales officer of Ideashpere, manufacture of Twin labs, vitamins, minerals,
      and nutritional supplements, Nature’s Herb and Alvita Teas for the health food
      industry, overseeing $120 million in annual sales. He began his career in the
      Nutraceutical business at Lenier Health Products where from 1981 to 2001 he
      spent 20 years, the majority heading sales as Executive Vice President of sales
      and merchandising and a member of the executive management group. P & L
      responsibility of $700 million. Direct responsibility for sales and
      merchandising. Cross functional responsibility for operations, customer service,
      and product development teams.




16





**Audit
      Committee Financial Expert**





The
      Company does not have an audit committee or a compensation committee of its
      board of directors. In addition, the Company’s board of directors has determined
      that the Company does not have an audit committee financial expert serving
      on
      the board. When the Company develops its operations, it will create an audit
      and
      a compensation committee and will seek an audit committee financial expert
      for
      its board and audit committee.





COMPLIANCE
      WITH SECTION 16(a) OF THE EXCHANGE ACT 9.A. DIRECTORS AND EXECUTIVE OFFICERS,
      PROMOTERS, AND CONTROL PERSONS:





The
      Company is aware that all filings of Form 4 and 5 required of Section 16(a)
      of
      the Exchange Act of Directors, Officers or holders of 10% of the Company's
      shares have not been timely and the Company has instituted procedures to ensure
      compliance in the future.





**ITEM
      10. EXECUTIVE COMPENSATION**





*General.* Mr.
      Scott
      Landow serves as the Company’s sole-director and chief executive officer.
      Pursuant to a Management Services Agreement executed and approved by the Company
      Mr. Landow was compensated approximately $120,000 for management fees and $6,000
      for fringe benefits, and other sources or forms of compensation was not paid
      or
      collected for Fiscal year ended 2007.





Mr.
      Eric
      Schick serves as the Company’s President. Mr. Schick is compensated
      approximately $120,000 for management fees.





**Summary
      Compensation Table**




The
      following table sets forth for the year ended December 31, 2007 and 2006
      compensation awarded to, paid to, or earned by, Mr.
      Scott  Landow,  our
      sole
      Director and Chief Executive Officer ,
      and  our
      three
      other most highly compensated executive officers whose total compensation during
      the last fiscal year exceeded $100,000, if any.




**2007
                and 2006 SUMMARY COMPENSATION TABLE**




**Name
                and Principal Position**
            
            **Year**
            
            **Salary ($)**
            
            **Bonus ($)**
            
            **Restricted
                Stock**
              **Awards**
              **($)**
            
            **Securities
                Underlying Option**
              **Awards**
              **($)**
            
            **Non-Equity**
              **Incentive
                Plan**
              **Compensation**
              **($)**
            
            **Change
                in**
              **Pension**
              **Value
                and**
              **Nonqualified**
              **Deferred**
              **Compensation**
              **Earnings**
              **($)**
            
            **All
                Other**
              **Compensation**
              **($)**
            
            **Total**
              **($)**Scott
                Landow
            
            2007
                & 2006
            
            
            120,000.
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            6,000
            
            
            126,000Eric
                Schick
            
            2006
                & 2007
            
            
            120,000
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0




17




**OPTION
                EXERCISES AND STOCK VESTED TABLE**




**Option
                Awards**
            
            **Stock
                Awards****Name**
            
            **Number of Shares**
              **Acquired on Exercise**
              **(#)**
            
            **Value Realized**
              **on
                Exercise**
              **($)**
            
            **Number of Shares**
              **Acquired on Vesting**
              **(#)**
            
            **Value Realized**
              **on
                Vesting**
              **($)**Scott
                Landow
            
            
            0
            
            
            0
            
            
            0
            
            
            0Eric
                Schick




**PENSION
                BENEFITS TABLE**




**Name**
            
            **Plan Name**
            
            **Number of Years**
              **Credited
                Service**
              **(#)**
            
            **Present Value**
              **of Accumulated**
              **Benefit**
              **($)**
            
            **Payments During Last**
              **Fiscal
                Year**
              **($)**Scott
                Landow
            
            
            (1)
            
            
            0
            
            
            0
            
            
            0Erick
                Schick




**Name**
            
            **Executive
                Contributions**
              **in
                Last Fiscal Year**
              **($)**
            
            **Registrant**
              **Contributions
                in Last**
              **Fiscal
                Year**
              **($)**
            
            **Aggregate
                Earnings in Last Fiscal Year**
              **($)**
            
            **Aggregate
                Withdrawals /**
              **Distributions**
              **($)**
            
            **Aggregate
                Balance at**
              **Last
                Fiscal Year-End**
              **($)**Scott
                Landow
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0Eric
                Schick
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0








**Name**
            
            **Fees**
              **Earned
                or**
              **Paid
                in Cash**
              **($)**
            
            **Stock
                Awards**
              **($)**
            
            **Option
                Awards**
              **($)**
            
            **Non-Equity
                Incentive Plan Compensation**
              **($)**
            
            **Change
                in Pension**
              **Value
                and**
              **Nonqualified
                Deferred Compensation Earnings**
              **($)**
            
            **All
                Other**
              **Compensation**
              **($)**
            
            **Total**
              **($)**Scott
                Landow
            
            $
            0
            
            
            0
            
            $
            0
            
            
            0
            
            
            0
            
            
            0
            
            $
            0Eric
                Schick
            
            $
            0
            
            
            0
            
            $
            0
            
            
            0
            
            
            0
            
            
            0
            
            $
            0




18




**Name**
            
            **Year**
            
            **Perquisites**
              **and
                Other Personal Benefits**
              **($)**
            
            **Tax
                Reimbursements**
              **($)**
            
            **Insurance
                Premiums**
              **($)**
            
            **Company
                Contributions**
              **to
                Retirement and 401(k) Plans**
              **($)**
            
            **Severance
                Payments / Accruals**
              **($)**
            
            **Change
                in Control Payments / Accruals**
              **($)**
            
            **Total**
              **($)**Scott
                Landow
            
            2007
                & 2006
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0Eric
                Schick
            
            2007
                & 2006
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0




**Name**
            
            **Year**
            
            **Personal
                Use of Company Car/Parking**
            
            **Financial
                Planning/ Legal Fees**
            
            **Club
                Dues**
            
            **Executive
                Relocation**
            
            **Total
                Perquisites and**
              **Other
                Personal Benefits**Scott
                Landow
            
            2007
                & 2006
            
            $
            6,000
            
            
            0
            
            
            0
            
            
            0
            
            $
            6,000Erick
                Schick
            
            2007
                & 2006
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0




**Name**
            
            **Benefit**
            
            **Before
                Charge in Control Termination w/o Cause or for Good
                Reason**
            
            **After
                Change in Control Termination w/o Cause or for Good
                Reason**
            
            **Voluntary
                Termination**
            
            **Death**
            
            **Disability**
            
            **Change
                in Control**Scott
                Landow
            
            Severance
            
            
            
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0Eric
                Schick
            
            
            
            
            
            
            
            0
            
            
            0
            
            
            0
            
            
            0
            
            
            0




**Compensation
      of BOD Member**




We
      currently have one director. Our current compensation policy for directors
      is to compensate them through options to purchase common stock as consideration
      for their joining our board and/or providing continued services as a director.
      We do not currently provide our directors with cash compensation, although
      we do
      reimburse their expenses, with exception for a chairman of the board. No
      additional amounts are payable to the Company’s directors for committee
      participation or special assignments. There are no other arrangements pursuant
      to which any directors was compensated during the Company’s last completed
      fiscal year for any service provided.




19




**ITEM
      11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND RELATED STOCKHOLDER
      MATTERS.**




The
      following table lists stock ownership of our Common Stock as of January 24,
      2008. The information includes beneficial ownership by (i) holders of more
      than
      5% of our Common Stock, (ii) each of two directors and executive officers
      and (iii) all of our directors and executive officers as a group. Except as
      noted below, to our knowledge, each person named in the table has sole voting
      and investment power with respect to all shares of our Common Stock beneficially owned by them.


Name
                  and Address of Owner
              
              Title
                  of Class
              
              Number
                of
                  Shares
                Owned
                  (1)
              
              Percentage
                of
                  Class (1)Scott
                  Landow
                777
                  South Highway 101, Suite 215
                Solana
                  Beach, CA 92975 (1)
              
              Common
                  Stock
              
              
              87,000
              
              
              
              (2)Eric
                  Schick
                777
                  South Highway 101, Suite 215
                Solana
                  Beach, CA 92975
              
              Common
                  Stock
              
              
              1,100,000
              
              
              6.06
              %All
                  Officers and Directors
                As
                  a Group (2 persons)
              
              Common
                  Stock
              
              
              1,187,000
              
              
              6.06
              %Small
                  World Traders
                777
                  South Highway 101, Suite 215
                Solana
                  Beach, CA 92975 (1)
              
              Common
                  Stock
              
              
              2,740,000
              
              
              15.11
              %WWFD
                  LLC
                777
                  South Highway 101, Suite 215
                Solana
                  Beach, CA 92975 (1)
              
              Common
                  Stock
              
              
              2,950,000
              
              
              16.27
              %William
                  Ritger
                750
                  Ocean Royal Way Suite 805
                Juno
                  Beach, FL 33408
              
              Common
                  Stock
              
              
              1,459,100
              
              
              8.05
              %Danker,
                  LLC
                5303
                  Channel Brook Court
                Dallas,
                  TX 75287
              
              Common
                  Stock
              
              
              1,039,000
              
              
              5.7
              %


(1)
              Beneficial
                  ownership is determined in accordance with the rules of the Securities
                  and
                  Exchange Commission and generally includes voting or investment
                  power with
                  respect to securities.  (2)
              Less
                than 1%




**Changes
      in Control**




We
      are
      not aware of any arrangements that may result in a change in control of the
      Company.




**DESCRIPTION
      OF SECURITIES**




**General**




Our
      authorized capital stock consists of 75,000,000 shares of common stock, par
      value $ .01, and 10,000,000 shares of preferred stock.




**Common
      Stock**




The
      shares of our common stock presently outstanding, and any shares of our common
      stock issues upon exercise of stock options and/or warrants, will be fully
      paid
      and non-assessable. Each holder of common stock is entitled to one vote for
      each
      share owned on all matters voted upon by shareholders, and a majority vote
      is
      required for all actions to be taken by shareholders. In the event we liquidate,
      dissolve or wind-up our operations, the holders of the common stock are entitled
      to share equally and ratably in our assets, if any, remaining after the payment
      of all our debts and liabilities and the liquidation preference of any shares
      of
      preferred stock that may then be outstanding. The common stock has no preemptive
      rights, no cumulative voting rights, and no redemption, sinking fund, or
      conversion provisions. Since the holders of common stock do not have cumulative
      voting rights, holders of more than 50% of the outstanding shares can elect
      all
      of our Directors, and the holders of the remaining shares by themselves cannot
      elect any Directors. Holders of common stock are entitled to receive dividends,
      if and when declared by the Board of Directors, out of funds legally available
      for such purpose, subject to the dividend and liquidation rights of any
      preferred stock that may then be outstanding.




20




*Voting
      Rights*





Each
      holder of Common Stock is entitled to one vote for each share of Common Stock
      held on all matters submitted to a vote of stockholders.





*Dividends*





Subject
      to preferences that may be applicable to any then-outstanding shares of
      Preferred Stock, if any, and any other restrictions, holders of Common Stock
      are
      entitled to receive ratably those dividends, if any, as may be declared from
      time to time by the Company’s board of directors out of legally available funds.
      The Company and its predecessors have not declared any dividends in the past.
      Further, the Company does not presently contemplate that there will be any
      future payment of any dividends on Common Stock.





**Preferred
      Stock**




We
      are
      authorized to issue 10,000,000 shares of preferred stock, $.01 par value, of
      which 5,000,000 are issued and outstanding as of August 31, 2006.




**Dividend
      Policy**




We
      have
      never declared or paid any cash dividends on our common stock. We currently
      intend to retain future earnings, if any, to finance the expansion of our
      business. As a result, we do not anticipate paying any cash dividends in the
      foreseeable future.





**Options
      and Warrants:**




As
      of December 31, 2007 there were no options to acquire shares of the Company’s
      common stock outstanding.





**Convertible
      Securities**





At
      December 31, 2007, the Company converted all convertible notes to common stock
      at $1.00 per share.




**Amendment
      of our Bylaws**




Our
      bylaws may be adopted, amended or repealed by the affirmative vote of a majority
      of our outstanding shares. Subject to applicable law, our bylaws also may be
      adopted, amended or repealed by our board of directors.




21





**Transfer
      Agent**





On
      August
      31, 2006, the Company engaged Colonial Transfer Agent to serve in the capacity
      of transfer agent. Their mailing address and telephone number Colonial Stock
      Transfer, 66 Exchange Place, Salt Lake City, UT 84111 - Phone is (801)
      355-5740.





**ITEM
      12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
      INDPENDENCE.**




During
      the year ended December 31, 2007 there were no related party advances. During
      the period July 26, 2005 (inception) through December 31, 2006, certain officers
      and stockholders advanced to the Company.  In
      addition, the CEO is to receive an annual bonus reflecting 50% of his then
      current salary, which he has elected to defer since inception.


December
      31, 2006




**Position**
            
            **Cash**
              **Advances**
            
            **Salary
                Deferred**
            
            **Amount**
              **Outstanding**
              **at**
              **December
                31,**
              **2006**Small
                World Traders, Inc.
            
            Scott
              Landow, through Landow Revocable Trust 2006 which is controlled by
              Scott
              Landow, controls Small World Traders, Inc.
            
            $
            99,247.92
            
            
            
            
            $
            99,247.92Scott
                Landow
            
            Director,
              CEO, CFO
            
            
            
            
            $
            200,000
            
            $
            200,000




**ITEM
      13. EXHIBITS**




**Exhibits**


3.1
              
              Articles
                  of Incorporation (1)3.2
              
              Amendments
                  to Articles of Incorporation (1)3.1
              
              Bylaws
                  of the Corporation (1)10.1
              
              Employment
                  Agreement Scott Landow (1)10.2
              
              Securities
                  Purchase Agreement (1)31.1
              
              Certification
                  of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley
                  Act. (2)31.2
              
              Certification
                  of Principal Financial and Accounting Officer Pursuant to Section
                  302 of
                  the Sarbanes-Oxley Act. (2)32.1
              
              Certification
                  of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley
                  Act. (2)32.2
              
              Certification
                  of Chief Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley
                  Act. (2)









(1).
      Incorporated by reference to the same exhibit filed with Amendment No. 3 to
      the
      Company’s Registration Statement on Form SB2 (Commission File No.
      333-137170).




(2)
      Filed
      herein.





**Reports
      on Form 8-K**





None




22





**ITEM
      14. PRINCIPLE ACCOUNTANT FEES AND SERVICES**





**Audit
      Fees.** The
      aggregate fees billed by Jewett, Schwartz, Wolfe & Associates **** for
      professional services rendered for the audit of the Company’s annual financial
      statements for the fiscal years ended December 31, 2007 of approximately $17,000
      and December 31, 2006 approximated $12,000.





**Audit-Related
      Fees.** The
      aggregate fees billed by **** Jewett,
      Schwartz, Wolfe & Associates **** for
      assurance and related services that are reasonably related to the performance
      of
      the audit or review of the Company’s financial statements for the fiscal year
      ended December 31 2005 and 2006, and that are not disclosed in the paragraph
      captioned “Audit Fees” above, were $0 and $0, respectively.





**Tax
      Fees.** The
      aggregate fees billed by Jewett, Schwartz, Wolfe & Associates for
      professional services rendered for tax compliance, tax advice and tax planning
      for the fiscal year ended December 31, 2006 and 2006 were $0.





**All
      Other Fees.** The
      aggregate fees billed by Jewett, Schwartz, Wolfe & Associates **** for
      products and services, other than the services described in the paragraphs
      “Audit Fees,” “Audit-Related Fees,” and “Tax Fees” above for the fiscal years
      ended December 31, 2006 and 2006 were $0 and $0, respectively.




23





**ITEM
      15. SIGNATURES.**




**SIGNATURES**





In
      accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934,
      the
      Registrant has duly caused this report to be signed on its behalf by the
      undersigned, there unto duly authorized.




Registrant
            *Bond
              Laboratories, Inc.*Date:
                March 28, 2008
            *By:*
            */s/
                Scott Landow*Scott
                LandowChairman,
                Chief Executive Officer
              (Principle
                Executive Officer)


Date:
                March 28, 2008
            *By:*
            */s/
              Scott Landow*Scott
                LandowPrinciple
                Financial Officer




24